ATP site-directed kinase inhibitors.

ATP site-directed kinase inhibitors. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

ATP site-directed kinase inhibitors. Abstract Text:

This symposium was organised by Dr Michael South (Monsanto/Searle Discovery Research, USA), and Dr Alex Bridges (Parke-Davis, MI USA), as a half-day symposium within the Medicinal Chemistry Division of the ACS. It was intended to provide an update to the chemical community of recent develop-ments in signal transduction enzymes, especially the progress towards clinical evaluation of a number of classes of ATP site-directed inhibitors. This is a rapidly expanding field, as judged by both the near capacity attendance and the number of additional posters on this subject at the meeting. Michael South opened the symposium with the comment that there were a large number of kinase enzymes now known. These show considerable homology at the ATP site, and it was thus originally expected that inhibitors targeting this site were unlikely to be selective. However, the discovery of potent and selective ATP site inhibitors has been a major step forward in the development of clinical agents.

ATP site-directed kinase inhibitors. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

ATP site-directed kinase inhibitors. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: IDrugs : the investigational drugs journal

VOLUME: 1

Page Numbers: 10-2

Journal Abbreviation:

ISSN: 1369-7056

DAY: 9

MONTH: May

YEAR: 1998

ATP site-directed kinase inhibitors. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100883655

ATP site-directed kinase inhibitors. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: ATP site-directed kinase inhibitors. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for ATP site-directed kinase inhibitors.

AFFILIATION: Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, New Zealand. b.denny@auckland.ac.nz.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: IDrugs

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

ATP site-directed kinase inhibitors Related Publications

• ATP site-directed kinase inhibitors.
• An overview of the role of diet during the ageing process.
• Big and tall parents do not have more sons.
• Changes in cerebral hemodynamics in preterm infants with and without patent ductus arteriosus.
• Construction of YAC libraries with large inserts.
• Dysplasia epiphysialis punctata; report of a case and review of literature.
• Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota.
• Forum on research and scholarly activity.
• Gender And Age Related Changes In Strength And Submaximal Performance Outcomes For Individuals With CHF: 2240: Board #153 June 1 8:00 AM - 9:30 AM.
• Intermediates in the reduction of the antituberculosis drug PA-824, (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, in aqueous solution.
• Percutaneous imaging-guided core breast biopsy: 5 years' experience in a community hospital.
• Pharmacokinetic/pharmacodynamic model-guided identification of hypoxia-selective 1,2,4-benzotriazine 1,4-dioxides with antitumor activity: the role of extravascular transport.
• Phosphoinositide-3-kinases (PI3Ks): Combined Comparative Modeling and 3D-QSAR To Rationalize the Inhibition of p110alpha.
• Placement and management of long-term central venous access catheters and ports.
• Quality assurance program for peripheral blood mononuclear cell cryopreservation.
• Queuing up for quality. Boosting quality with electronic work queues.
• Retroperitoneal hemorrhage after percutaneous nephrostomy.
• Safety and Effectiveness of Progressive Resistance TVaining in Heart Failure Patients: 2242: Board #155 June 1 8:00 AM - 9:30 AM.
• Salivary mucin as related to oral Streptococcus mutans in elderly people.
• Synthesis and structure-activity relationships of soluble 8-substituted 4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of the Wee1 and Chk1 checkpoint kinases.
• The global health and diagnostic (flow) cytometry--breakthroughs in HIV and tuberculosis.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• Use of the balloon on a guidewire as an adjunct to conventional angioplasty.
• Women's journey of recovery from sexual assault trauma: a grounded theory--part 1.
• Women's journey of recovery from sexual assault trauma: a grounded theory--part 2.